Literature DB >> 20164267

Molecular typing of pneumococci for investigation of linked cases of invasive pneumococcal disease.

Bruno Pichon1, Laura Moyce, Carmen Sheppard, Mary Slack, Deborah Turbitt, Richard Pebody, David A Spencer, Justin Edwards, Daniel Krahé, Robert George.   

Abstract

In winter 2007-2008, an outbreak of pediatric pneumonia caused by serotype 5 pneumococci was identified in a northeast London suburb. Variable number of tandem repeat analyses clustered these pneumococci from the other serotype 5 pneumococci in the United Kingdom, highlighting the importance of this discriminative typing method in supporting epidemiological investigations.

Entities:  

Mesh：

Year:  2010        PMID： 20164267      PMCID： PMC2863872          DOI： 10.1128/JCM.02054-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  9 in total

1.  Molecular typing of pneumococci causing parapneumonic empyema in Spanish children using multilocus sequence typing directly on pleural fluid samples.

Authors:  Ignacio Obando; Luis A Arroyo; David Sánchez-Tatay; David Moreno; William P Hausdorff; Angela B Brueggemann
Journal:  Pediatr Infect Dis J       Date:  2006-10       Impact factor: 2.129

2.  A bioinformatics pipeline for high-throughput microbial multilocus sequence typing (MLST) analyses.

Authors:  S Platt; B Pichon; R George; J Green
Journal:  Clin Microbiol Infect       Date:  2006-11       Impact factor: 8.067

3.  Outbreak of Streptococcus pneumoniae serotype 1 pneumonia in a United Kingdom school.

Authors:  Atul Gupta; F-M Khaw; E L Stokle; R C George; R Pebody; R E Stansfield; C L Sheppard; M Slack; R Gorton; D A Spencer
Journal:  BMJ       Date:  2008-12-31

4.  Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity.

Authors:  P R Hunter; M A Gaston
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

Review 5.  The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease.

Authors:  William P Hausdorff
Journal:  Vaccine       Date:  2006-09-18       Impact factor: 3.641

Review 6.  Epidemiological differences among pneumococcal serotypes.

Authors:  William P Hausdorff; Daniel R Feikin; Keith P Klugman
Journal:  Lancet Infect Dis       Date:  2005-02       Impact factor: 25.071

7.  Age- and serotype-specific pediatric invasive pneumococcal disease: insights from systematic surveillance in Santiago, Chile, 1994--2007.

Authors:  Rosanna Lagos; Alma Muñoz; Oriana San Martin; Aurora Maldonado; Juan Carlos Hormazabal; William C Blackwelder; Myron M Levine
Journal:  J Infect Dis       Date:  2008-12-15       Impact factor: 5.226

8.  Genetic characteristics of pneumococcal disease in elderly patients before introducing the pneumococcal conjugate vaccine.

Authors:  B Pichon; H V Bennett; A Efstratiou; M P E Slack; R C George
Journal:  Epidemiol Infect       Date:  2009-01-23       Impact factor: 2.451

9.  Evaluation and selection of tandem repeat loci for Streptococcus pneumoniae MLVA strain typing.

Authors:  Jean-Louis Koeck; Berthe-Marie Njanpop-Lafourcade; Sonia Cade; Emmanuelle Varon; Lassana Sangare; Samina Valjevac; Gilles Vergnaud; Christine Pourcel
Journal:  BMC Microbiol       Date:  2005-11-16       Impact factor: 3.605
  9 in total
  9 in total

1.  Population structure of hyperinvasive serotype 12F, clonal complex 218 Streptococcus pneumoniae revealed by multilocus boxB sequence typing.

Authors:  Alexey V Rakov; Kimiko Ubukata; D Ashley Robinson
Journal:  Infect Genet Evol       Date:  2011-08-25       Impact factor: 3.342

2.  Use of a serotype-specific urine immunoassay to determine the course of a hospital outbreak of Streptococcus pneumoniae complicated by influenza A.

Authors:  Carmen L Sheppard; John Clark; Mary P E Slack; Norman K Fry; Timothy G Harrison
Journal:  JMM Case Rep       Date:  2016-02-12

3.  Serotype 10A in case patients with invasive pneumococcal disease: a pilot study of PCR-based serotyping in New Jersey.

Authors:  Samantha I Pitts; Andria Apostolou; Sarmila DasGupta; Nelson Delgado; Thomas J Kirn; Barbara Montana; Christina Tan; Lisa A McHugh
Journal:  Public Health Rep       Date:  2015 Jan-Feb       Impact factor: 2.792

4.  Serotype 5 pneumococci causing invasive pneumococcal disease outbreaks in Barcelona, Spain (1997 to 2011).

Authors:  Dora Rolo; Asunción Fenoll; Dionísia Fontanals; Nieves Larrosa; Montserrat Giménez; Immaculada Grau; Román Pallarés; Josefina Liñares; Carmen Ardanuy
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

5.  Multiple-locus variable number tandem repeat analysis for Streptococcus pneumoniae: comparison with PFGE and MLST.

Authors:  Karin E M Elberse; Sónia Nunes; Raquel Sá-Leão; Han G J van der Heide; Leo M Schouls
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

6.  Modified MLVA for Genotyping Queensland Invasive Streptococcus pneumoniae.

Authors:  Rachael E Rayner; John Savill; Louise M Hafner; Flavia Huygens
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

7.  MLVA Typing of Streptococcus pneumoniae Isolates with Emphasis on Serotypes 14, 9N and 9V: Comparison of Previously Described Panels and Proposal of a Novel 7 VNTR Loci-Based Simplified Scheme.

Authors:  Natália S Costa; Tatiana C A Pinto; Vânia L C Merquior; Luciana F S Castro; Filomena S P da Rocha; Jaqueline M Morais; José M Peralta; Lúcia M Teixeira
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

Review 8.  Streptococcus pneumoniae outbreaks and implications for transmission and control: a systematic review.

Authors:  Paul N Zivich; John D Grabenstein; Sylvia I Becker-Dreps; David J Weber
Journal:  Pneumonia (Nathan)       Date:  2018-11-05

9.  Multiple-locus variable-number tandem-repeat analysis of Streptococcus pneumoniae and comparison with multiple loci sequence typing.

Authors:  Hélène van Cuyck; Bruno Pichon; Philippe Leroy; Alexandra Granger-Farbos; Anthony Underwood; Bruno Soullié; Jean-Louis Koeck
Journal:  BMC Microbiol       Date:  2012-10-22       Impact factor: 3.605
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.